CONMED Corp — Director's Dealing 2018

Mar 5, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2018-03-01

Reporting Person: JONAS DANIEL (EVP Legal Affairs,Gen. Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-01	Common Stock	M	1025	—	Acquired	18499	Direct
2018-03-01	Common Stock	F	352	$59.96	Disposed	18147	Direct
2018-03-01	Common Stock	M	350	—	Acquired	18497	Direct
2018-03-01	Common Stock	F	116	$59.96	Disposed	18381	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-01	Rsus (restricted Stock Units)	$0	M	1025	Disposed	2025-02-27	Common Stock (1025)	Direct
2018-03-01	Rsus (restricted Stock Units)	$0	M	350	Disposed	2026-03-01	Common Stock (350)	Direct
2018-03-01	Options To Purchase Common Stock	$59.96	A	27000	Acquired	2028-03-01	Common Stock (27000)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.

F3: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period